Constipation Clinical Trial
— MANOCOHROfficial title:
Usefulness of High Resolution Manometry in Constipation
Constipation is a frequent symptom that is reported by more than 10% of the general population. In a few case, constipation is resistant to medical standard care, including osmotic and stimulant laxatives. The diagnosis of colonic inertia may be suspected in these patients although diagnostic criteria for colonic inertia may vary from one country to another. In France, the diagnosis of colonic inertia is based on manometric study of the colorectal contractile activity using manometric probe. Using conventional manometric catheters, severe alteration of the colorectal motility is found in a very small subset of patients, who may later benefit from surgery. The recent use of high resolution manometric probe allowed to map more precisely colorectal motility, but whether these new parameters are relevant remains to be assessed. The aim of this study is to assess the diagnostic performance of a new high resolution manometric probe by comparing healthy volunteers to patients suspected of colonic inertia.
Status | Not yet recruiting |
Enrollment | 76 |
Est. completion date | September 2024 |
Est. primary completion date | September 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | For patient Inclusion Criteria: - Age between 18 and 65 years - chronic Constipation (> 6 months) - delayed colonic transit time > 100 h - normal colonoscopy - constipation refractory to at least 1 osmotic and 1 stimulant laxative according French guidelines on constipation ; - Affiliated to French national healthcare insurance Exclusion Criteria: - Patient with constipation being either: - With colonic transit time <100h - Distal (with radio-opaque markers stasis in the rectum) - From organic origin - Recent (<6 mois) - Relieved using osmotic or stimulant laxatives - Contra-indication to the use of high resolution manometry insertion - Intestinal occlusion - Coagulation disorders, including anti-coagulant treatments - General anesthesia contra-indication - colonoscopy contra-indication - failure to perform a colonoscopy in previous attempts - medication intake that may impair colorectal motility, including opioids - Evolutive inflammatory of neoplasia process - History of major digestive surgery (at exclusion of appendicectomy, cholecystectomy) - Presence of condition that may impact digestive motility, including diabetes mellitus and sclerodermia - Cardiologic disease that may represent a contraindication to vagal stimulation For Healthy volunteers Inclusion Criteria: - Age between 18 and 65 years - Affiliated to French national healthcare insurance Exclusion Criteria: - Significant digestive evolutive disease - constipation with Kess score > 11/39 and colonic transit time = 60 h - Contra-indication to the use of high resolution manometry insertion - Intestinal occlusion - Cardiac disease - Coagulation disorders, including anti-coagulant treatments - General anesthesia contra-indication - colonoscopy contra-indication - History of major digestive surgery (at exclusion of appendicectomy, cholecystectomy) - Presence of condition that may impact digestive motility, including diabetes mellitus and sclerodermia |
Country | Name | City | State |
---|---|---|---|
France | Rouen University Hospital | Rouen |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Rouen |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Frequency of isolated propagated colonic contractions | Number of colonic contractions during 24 hours | 24 hours | |
Secondary | Speed of isolated propagated colonic contractions | Average speed of colonic contractions during 24 hours | 24 hours | |
Secondary | Colonic transit time | Transit time will be measured during during the first 24 hours | during the first 24 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Recruiting |
NCT06292949 -
Clinical Study of Resistant Starch in Improving Constipation
|
N/A | |
Recruiting |
NCT04132661 -
MRI Assessment of Mode of Action of Bisacodyl, Single Dose
|
Phase 4 | |
Completed |
NCT02726295 -
The Efficacy of Mutaflor(E. Coli Nissle 1917, Mutaflor®) for Chronic Constipation:Multicenter Study
|
Phase 4 | |
Terminated |
NCT02839889 -
Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)
|
Phase 4 | |
Recruiting |
NCT02255747 -
Anal Dilatation for Infants and Children With Constipation
|
N/A | |
Completed |
NCT02246647 -
Biomarkers for Intestinal Permeability in Patients With Constipation
|
||
Completed |
NCT01566409 -
Maintenance Treatment for Children With Constipation
|
N/A | |
Completed |
NCT02658201 -
Ultrafast MRI Imaging to Exclude Constipation
|
N/A | |
Completed |
NCT01710579 -
Normal Values in Ano-rectal 3D High Resolution Manometry
|
N/A | |
Completed |
NCT01695915 -
Diurnal Variation in Rectal Diameter
|
N/A | |
Completed |
NCT02863848 -
Effect of Inulin-type Fructans on Constipated Children.
|
N/A | |
Completed |
NCT01474499 -
A Trial of Docusate Sodium and Sorbitol Rectal Solution for the in Patients With Constipation
|
Phase 3 | |
Completed |
NCT01411501 -
Efficacy and Safety of Acupuncture for Functional Constipation
|
Phase 3 | |
Completed |
NCT01438567 -
A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer Therapy
|
Phase 3 | |
Completed |
NCT00931853 -
Efficacy and Tolerability of Cassia Fistula Plus Senna Alexandrina Miller (Sugar Free) in the Chronic Functional Constipation (CFC).
|
Phase 3 | |
Completed |
NCT01170039 -
The Effectiveness of Lubiprostone in Constipated Diabetics
|
Phase 4 | |
Active, not recruiting |
NCT02442115 -
Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
|
||
Completed |
NCT00994851 -
Evaluation of Cassia Fistula + Senna Alexandrina Miller in the Chronic Functional Constipation Treatment.
|
Phase 3 | |
Terminated |
NCT01003249 -
Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen
|
Phase 4 |